Product & Industry News
Page 1 to 16 of 148 |     NEXT PAGE >
Helperby Therapeutics Announces Phase 1 Results
Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique combination antibiotic therapy - effective against the WHO Critical Priority Carbapenem resistant bacterial pathogens

Read More

Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology
Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.

Read More

Torque Presents Preclinical Data at AACR
Torque Presents Preclinical Data at AACR Demonstrating that Deep-Primed IL-15 and Deep-Primed IL-12 Anchored to T Cells are Superior to Systemically Administered IL-15 and IL-12 for Increasing T Cell Infiltration and Tumor Killing Without Systemic Toxicity

Read More

Nanobiotix Present Preclinical Data Showing at AACR 2018
NBTXR3 Nanoparticles can activate the cGAS-STING pathway

Read More

PATH and Mologic advance a new diagnostic test to support malaria elimination
PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria.

Read More

CheckMate -227 Met its Co-primary Endpoint of Progression-free Survival
First-line nivolumab-ipilimumab combo improved progression-free survival in patients with advanced non-small cell lung cancer with high tumor mutational burden.

Read More

PhoreMost and Plexxikon collaborate to identify novel drug targets
PhoreMost, a biopharmaceutical company dedicated to drugging 'undruggable' disease targets, has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

Read More

Two Global Cancer Leaders Announce Ambitious Strategic Alliance
The American Association for Cancer Research (AACR), and Cancer Research UK (CRUK), are launching an ambitious new international alliance to speed the pace of progress against cancer.

Read More

Horizon enters into partnership with Pirbright Institute
Horizon enters into partnership with Pirbright Institute to support research into improvement of vaccine yields.

Read More

Enterprise Therapeutics Raises £29 Million ($41 Million USD) Funding
Enterprise has announced that it has closed an oversubscribed £29 million Series B round co-led by Versant Ventures and Novartis Venture Fund.

Read More

Symcel partners with Karolinska Institutet
Symcel partners with Karolinska Institutet to validate calScreener in clinical antimicrobial susceptibility testing

Read More

Thermo Fisher Launches 5 New Products At Analytica 2018
Thermo Fisher Scientific is launching five new solutions in instrumentation, data management, sample preparation and consumables at Analytica 2018 (Messe München, booth 101, hall B1) in Munich, Germany.

Read More

Gustave Roussy and Protagen AG collaborate
This collaboration will utilize Protagen’s SeroTag technology to help identify biomarkers that predict and monitor immune-related adverse events (irAEs) in cancer patients treated with checkpoint inhibitors.

Read More

Owlstone Medical provides Breath Biopsy Services to AstraZeneca
Collaboration will explore use of Breath Biopsy to identify novel biomarkers to enable personalized medicine applications.

Read More

Ubiquigent & Forma Therapeutics Enter An Exclusive R&D Collaboration
Ubiquigent Limited announced that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors.

Read More

IONTAS and IGEM Therapeutics collaborate to identify novel IgE antibodies for cancer targets
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, announced that it will collaborate with IGEM Therapeutics, an immuno-oncology company developing novel IgE antibodies to treat cancer.

Read More

Product & Industry News
Page 1 to 16 of 148 |     NEXT PAGE >